• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普鲁士蓝的长期稳定性研究——水分含量和铊结合的质量评估

Long-term stability study of Prussian blue - a quality assessment of water content and thallium binding.

作者信息

Mohammad Adil, Faustino Patrick J, Khan Mansoor A, Yang Yongsheng

机构信息

Food and Drug Administration, Center for Drug Evaluation and Research, Office of Testing and Research, Division of Product Quality Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.

Food and Drug Administration, Center for Drug Evaluation and Research, Office of Testing and Research, Division of Product Quality Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.

出版信息

Int J Pharm. 2014 Dec 30;477(1-2):122-7. doi: 10.1016/j.ijpharm.2014.10.020. Epub 2014 Oct 11.

DOI:10.1016/j.ijpharm.2014.10.020
PMID:25311178
Abstract

The purpose of this study is to assess the long-term stability of Prussian blue (PB) drug product (DP) and active pharmaceutical ingredient (API) under laboratory storage conditions by monitoring the loss in water content and the corresponding change of the in vitro thallium binding capacity that represents product performance. The bound water content and the in vitro thallium binding capacity of PB DPs and APIs were measured in 2003 and 2013, respectively. Water content, a critical quality attribute that directly correlates to the thallium (Tl) binding capacity was measured by thermal gravimetric analysis (TGA). The thallium binding study was conducted by testing PB in buffered solutions over the human gastrointestinal pH range with thallium concentrations ranging from 600 to 1,500 ppm. Samples were incubated at physiological temperature of 37°C in a shaking water bath to mimic gastric flux and intestinal transport. The binding equilibrium was reached at 24h. Following incubation, each sample was filtered and the free thallium was analyzed using a validated inductively coupled plasma spectroscopic method (ICP). The Langmuir isotherm was plotted to calculate maximum binding capacity (MBC). Compared with 2003, the water content of DP-1 decreased by about 14.1% (from 15.6 to 13.4 mol), and the MBC of DP-1 decreased by about 12.5% (from 714 to 625 mg/g) at pH 7.5. When low concentration of thallium (600 ppm) was used at pH 7.5, the Tl binding remained comparable for both API-1 (286 vs 276 mg/g) and DP-1 (286 vs 268 mg/g). Similarly, the Tl binding remained unchanged for both API-1 (237 vs 255 mg/g) and DP-1 (234 vs 236 mg/g) at pH 5.0. However, at pH 1.0 the binding was reduced 32.3% and 25.9% for API-1 and DP-1, respectively. Since the majority of binding takes place in the upper GI tract where pH around 5 can be expected, and therefore, the Tl binding capacity of PB should be comparable for new and aged samples. The findings that Tl binding changes with the water loss of PB and pH conditions are consistent with our previously published data. The study also represents the first quantitative assessment of the long-term stability of PB. Over last 10 years, PB DPs and APIs have lost about 20% water under ambient laboratory storage conditions which are consistent with a controlled warehouse environment. While the maximum binding capacity of PB to thallium was decreased after about 10 years of long-term storage, it is still very effective, suggesting that the shelf life of PB should be much longer than the manufacturer ascribed expiration date of 2008 under proper storage conditions.

摘要

本研究的目的是通过监测水分含量的损失以及代表产品性能的体外铊结合能力的相应变化,评估普鲁士蓝(PB)药品(DP)和活性药物成分(API)在实验室储存条件下的长期稳定性。分别于2003年和2013年测量了PB DP和API的结合水含量和体外铊结合能力。水分含量是与铊(Tl)结合能力直接相关的关键质量属性,通过热重分析(TGA)进行测量。铊结合研究是通过在人胃肠道pH范围内的缓冲溶液中测试PB进行的,铊浓度范围为600至1500 ppm。样品在37°C的生理温度下于振荡水浴中孵育,以模拟胃蠕动和肠道转运。24小时达到结合平衡。孵育后,每个样品进行过滤,使用经过验证的电感耦合等离子体光谱法(ICP)分析游离铊。绘制朗缪尔等温线以计算最大结合能力(MBC)。与2003年相比,DP - 1的水分含量下降了约14.1%(从15.6降至13.4摩尔),在pH 7.5时DP - 1的MBC下降了约12.5%(从714降至625 mg/g)。当在pH 7.5使用低浓度铊(600 ppm)时,API - 1(286对276 mg/g)和DP - 1(286对268 mg/g)的Tl结合保持相当。同样,在pH 5.

相似文献

1
Long-term stability study of Prussian blue - a quality assessment of water content and thallium binding.普鲁士蓝的长期稳定性研究——水分含量和铊结合的质量评估
Int J Pharm. 2014 Dec 30;477(1-2):122-7. doi: 10.1016/j.ijpharm.2014.10.020. Epub 2014 Oct 11.
2
A long-term stability study of Prussian blue: A quality assessment of water content and cesium binding.普鲁士蓝的长期稳定性研究:水分含量与铯结合的质量评估
J Pharm Biomed Anal. 2015 Jan 25;103:85-90. doi: 10.1016/j.jpba.2014.10.030. Epub 2014 Nov 6.
3
Quantitative determination of thallium binding to ferric hexacyanoferrate: Prussian blue.铊与六氰合铁酸铁(普鲁士蓝)结合的定量测定
Int J Pharm. 2008 Apr 2;353(1-2):187-94. doi: 10.1016/j.ijpharm.2007.11.031. Epub 2007 Nov 23.
4
Long-term stability study of Prussian blue-A quality assessment of water content and cyanide release.普鲁士蓝-A的长期稳定性研究——水分含量和氰化物释放的质量评估
Clin Toxicol (Phila). 2015 Feb;53(2):102-7. doi: 10.3109/15563650.2014.998337. Epub 2015 Jan 22.
5
Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue.铯与六氰合铁酸铁(普鲁士蓝)结合的定量测定
J Pharm Biomed Anal. 2008 May 12;47(1):114-25. doi: 10.1016/j.jpba.2007.11.049. Epub 2007 Dec 14.
6
Quantitative evaluation of the thallium binding of soluble and insoluble Prussian blue hexacyanoferrate analogs: A scientific comparison based on their critical quality attributes.可溶性和不溶性普鲁士蓝六氰合铁酸盐类似物的铊结合定量评估:基于关键质量属性的科学比较。
Int J Pharm. 2019 Oct 5;569:118600. doi: 10.1016/j.ijpharm.2019.118600. Epub 2019 Aug 8.
7
Comparative efficacy of thallium adsorption by activated charcoal, prussian blue, and sodium polystyrene sulfonate.活性炭、普鲁士蓝和聚苯乙烯磺酸钠对铊吸附的比较疗效
J Toxicol Clin Toxicol. 1999;37(7):833-7. doi: 10.1081/clt-100102462.
8
Oral formulation of Prussian blue with improved efficacy for prophylactic use against thallium.用于预防铊中毒的疗效得到改善的普鲁士蓝口服制剂。
Drug Dev Ind Pharm. 2023 Feb;49(2):149-158. doi: 10.1080/03639045.2023.2189958. Epub 2023 Mar 22.
9
Quantitative measurement of cyanide released from Prussian Blue.普鲁士蓝释放氰化物的定量测定。
Clin Toxicol (Phila). 2007 Oct-Nov;45(7):776-81. doi: 10.1080/15563650601181562.
10
Thallium(I) sorption using Prussian blue immobilized in alginate capsules.藻酸盐胶囊固定普鲁士蓝吸附铊(I)。
Carbohydr Polym. 2014 Jan;99:517-26. doi: 10.1016/j.carbpol.2013.08.076. Epub 2013 Sep 1.

引用本文的文献

1
Investigation into recent advanced strategies of reactive oxygen species-mediated therapy based on Prussian blue: Conceptualization and prospect.基于普鲁士蓝的活性氧介导疗法近期先进策略的研究:概念化与展望
Bioact Mater. 2025 Feb 13;48:71-99. doi: 10.1016/j.bioactmat.2025.01.023. eCollection 2025 Jun.
2
In vitro and in vivo removal efficacy of insoluble Prussian blue in combination with calcium polystyrene sulfonate for thallium.普鲁士蓝不溶物联合聚苯乙烯磺酸钙经体内外实验验证对铊的去除效果。
Biometals. 2023 Oct;36(5):1125-1140. doi: 10.1007/s10534-023-00508-7. Epub 2023 May 24.
3
Excavating bioactivities of nanozyme to remodel microenvironment for protecting chondrocytes and delaying osteoarthritis.
挖掘纳米酶的生物活性以重塑微环境,保护软骨细胞并延缓骨关节炎。
Bioact Mater. 2021 Jan 29;6(8):2439-2451. doi: 10.1016/j.bioactmat.2021.01.016. eCollection 2021 Aug.
4
Prussian Blue Nanoparticles as a Versatile Photothermal Tool.普鲁士蓝纳米颗粒作为一种多功能光热工具。
Molecules. 2018 Jun 11;23(6):1414. doi: 10.3390/molecules23061414.